title: UPLC-MS-based urine metabolomics reveals indole-3-lactic acid and phenyllactic acid as conserved biomarkers for alcohol-induced liver disease in the Ppara-null mouse model.
abstract: Since the development and prognosis of alcohol-induced liver disease (ALD) vary significantly with genetic background, identification of a genetic background-independent noninvasive ALD biomarker would significantly improve screening and diagnosis. This study explored the effect of genetic background on the ALD-associated urinary metabolome using the Ppara-null mouse model on two different backgrounds, C57BL/6 (B6) and 129/SvJ (129S), along with their wild-type counterparts. Reversed-phase gradient UPLC-ESI-QTOF-MS analysis revealed that urinary excretion of a number of metabolites, such as ethylsulfate, 4-hydroxyphenylacetic acid, 4-hydroxyphenylacetic acid sulfate, adipic acid, pimelic acid, xanthurenic acid, and taurine, were background-dependent. Elevation of ethyl-β-d-glucuronide and N-acetylglycine was found to be a common signature of the metabolomic response to alcohol exposure in wild-type as well as in Ppara-null mice of both strains. However, increased excretion of indole-3-lactic acid and phenyllactic acid was found to be a conserved feature exclusively associated with the alcohol-treated Ppara-null mouse on both backgrounds that develop liver pathologies similar to the early stages of human ALD. These markers reflected the biochemical events associated with early stages of ALD pathogenesis. The results suggest that indole-3-lactic acid and phenyllactic acid are potential candidates for conserved and pathology-specific high-throughput noninvasive biomarkers for early stages of ALD.
authors: Laboratory of Metabolism, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland 20892, United States.
authors: Soumen K
authors: SK
authors: Manna
authors: Andrew D
authors: AD
authors: Patterson
authors: Qian
authors: Q
authors: Yang
authors: Kristopher W
authors: KW
authors: Krausz
authors: Jeffrey R
authors: JR
authors: Idle
authors: Albert J
authors: AJ
authors: Fornace
authors: Frank J
authors: FJ
authors: Gonzalez
mesh_terms: D000438:Alcohols / Q000378:metabolism; D000704:Analysis of Variance; D000818:Animals; D015415:Biomarkers / Q000378:metabolism / Q000652:urine*; D002851:Chromatography, High Pressure Liquid; D004195:Disease Models, Animal; D007211:Indoles / Q000378:metabolism / Q000652:urine*; D007773:Lactates / Q000378:metabolism / Q000652:urine*; D008108:Liver Diseases, Alcoholic / Q000652:urine*; D008297:Male; D013058:Mass Spectrometry; D053858:Metabolic Networks and Pathways; D055432:Metabolomics / Q000379:methods*; D051379:Mice; D018345:Mice, Knockout; D047493:PPAR alpha / Q000235:genetics / Q000378:metabolism*; D010649:Phenylalanine / Q000378:metabolism; D025341:Principal Component Analysis; D013654:Taurine / Q000378:metabolism / Q000652:urine; D014364:Tryptophan / Q000378:metabolism
chemical_list: D000438:Alcohols; D015415:Biomarkers; D007211:Indoles; D007773:Lactates; D047493:PPAR alpha; C017648:3-phenyllactic acid; D013654:Taurine; D010649:Phenylalanine; C024139:indole-3-lactic acid; D014364:Tryptophan